{
    "Trade/Device Name(s)": [
        "Rightest Blood Glucose Monitoring System, Model GM650",
        "GE Talking Blood Glucose Monitoring System, Model GE300"
    ],
    "Submitter Information": "Bionime Corporation",
    "510(k) Number": "K120423",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092052"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "July 9, 2012",
    "Summary Letter Received Date": "July 23, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Rightest Meter GM650",
        "GE300 Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection",
        "FAD-glucose Dehydrogenase (FADGDH) enzymatic reaction"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing Device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for Bionime Rightest Blood Glucose Monitoring System GM650 and GE Talking Blood Glucose Monitoring System GE300 for self-testing blood glucose levels using electrochemical technology",
    "Indications for Use Summary": "For single patient use at home by individuals with diabetes to quantitatively measure glucose in fresh capillary whole blood from fingertip, palm, and forearm as an aid to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}